Publication | Closed Access

Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

Solid TumorsMedicinePharmacologyMolar Ratio 1:0.4:1PharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyPharmacokineticsCancer ResearchOral Formulation